Impaired myocardial oxidative metabolism in the remote normal region in patients in the chronic phase of myocardial infarction and left ventricular remodeling

Journal of Nuclear Cardiology

Volumn 16, Issue 1, 2009, Pages 73-81

  Ohte, Nobuyuki ^a   Narita, Hitomi ^b   Iida, Akihiko ^b   Wakami, Kazuaki ^a   Asada, Kaoru ^a   Fukuta, Hidekatsu ^a   Kato, Takafumi ^a   Hyano, Junichiro ^a   Kimura, Genjiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Nagoya City Rehabilitation and Sports Center   (Japan)

Author keywords

Carbon 11 acetate; Coronary artery disease; PET imaging

Indexed keywords

ACETIC ACID C 11; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OXYGEN;

ACUTE HEART INFARCTION; AEROBIC METABOLISM; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HEART VENTRICLE REMODELING; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; CHRONIC DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; METABOLIC CLEARANCE RATE; METABOLISM; OXYGEN CONSUMPTION;

AGED; CHRONIC DISEASE; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MYOCARDIAL INFARCTION; OXYGEN; OXYGEN CONSUMPTION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 67649969908     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-008-9006-4     Document Type: Article

References (31)

1. Dutka DP, Camici PG. Hibernation and congestive heart failure. Heart Fail Rev 2003;8:167-73.
2. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-72.
3. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 1991;260:H1406-14.
4. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: Pathophysiology and therapy. Circulation 2000;101:2981-8.
5. Ohte N, Kurokawa K, Iida A, et al. Myocardial oxidative metabolism in remote normal regions in the left ventricles with remodeling after myocardial infarction: Effect of beta-adrenoceptor blockers. J Nucl Med 2002;43:780-5.
6. Braunwald E. Control of myocardial oxygen consumption: Physiologic and clinical considerations. Am J Cardiol 1971;27:416-32.
7. Porenta G, Cherry S, Czernin J, et al. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur J Nucl Med 1999;26:1465-74.
8. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
9. Nakano K, Sugawara M, Kato T, et al. Regional work of the human left ventricle calculated by wall stress and the natural logarithm of reciprocal of wall thickness. J Am Coll Cardiol 1988;12:1442-8.
10. Brown MA, Myears DW, Bergmann SR. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography. J Am Coll Cardiol 1988;12:1054-63.
11. Brown MA, Myears DW, Bergmann SR. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 1989;30:187-93.
12. Armbrecht JJ, Buxton DB, Schelbert HR. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 1990;81:1594-605.
13. Hattori N, Tamaki N, Kudoh T, et al. Abnormality of myocardial oxidative metabolism in noninsulin-dependent diabetes mellitus. J Nucl Med 1998;39:1835-40.
14. Tomanek RJ. Response of the coronary vasculature to myocardial hypertrophy. J Am Coll Cardiol 1990;15:528-33.
15. Kalkman EA, Bilgin YM, van Haren P, van Suylen RJ, Saxena PR, Schoemaker RG. Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding. Cardiovasc Res 1996;32:1088-95.
16. Holtz J, Restorff WV, Bard P, Bassenge E. Transmural distribution of myocardial blood flow and of coronary reserve in canine left ventricular hypertrophy. Basic Res Cardiol 1977;72:286-92.
17. Waller C, Hiller KH, Kahler E, et al. Serial magnetic resonance imaging of microvascular remodeling in the infarcted rat heart. Circulation 2001;103:1564-69.
18. Sano M, Minamino T, Toko H, et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007;446:444-8.
19. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993;88:993-1003.
20. Tanaka M, Fujiwara H, Onodera T, et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987;75:1130-9.
21. Gimelli A, Schneider-Eicke J, Neglia D, et al. Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: Two different patterns of myocardial perfusion associated with degree of hypertrophy. J Am Coll Cardiol 1998;31:366-73.
22. Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994;331:222-7.
23. Geshi T, Nakano A, Uzui H, et al. Relationship between impaired microvascular function in the non-infarct-related area and left-ventricular remodeling in patients with myocardial infarction. Int J Cardiol 2008;126:366-73.
24. Goto T, Ohte N, Miyabe H, et al. Tl-201 washout rate in remote normal regions in patients with prior myocardial infarction and left ventricular remodeling. J Nucl Cardiol 2005;12:179-85.
25. Vinereanu D, Ionescu A, Fraser AG. Assessment of left ventricular long axis contraction can detect early myocardial dysfunction in asymptomatic patients with severe aortic regurgitation. Heart 2001;85:30-6.
26. Vinereanu D, Nicolaides E, Tweddel AC, et al. Subclinical left ventricular dysfunction in asymptomatic patients with Type 2 diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci 2003;105:591-9.
27. Ohte N, Narita H, Miyabe H, et al. Evaluation of whole left ventricular systolic performance and local myocardial systolic function in patients with prior myocardial infarction using global long-axis myocardial strain. Am J Cardiol 2004;94:929-32.
28. Wu YW, Naya M, Tsukamoto T, et al. Heterogeneous reduction of myocardial oxidative metabolism in patients with ischemic and dilated cardiomyopathy using C-11 acetate PET. Circ J 2008;72:786-92.
29. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9.
30. Hall JL, Stanley WC, Lopaschuk GD, et al. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. Am J Physiol 1996;271:H2320-9.
31. Toyoda K, Nakano A, Fujibayashi Y, Yonekura Y, Ueda T, Lee JD. Diabetes mellitus impairs myocardial oxygen metabolism even in non-infarct-related areas in patients with acute myocardial infarction. Int J Cardiol 2007;115:297-304.